A citation-based method for searching scientific literature

Douglas J Veale, Ursula Fearon. Lancet 2018
Times Cited: 191







List of co-cited articles
733 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Psoriatic Arthritis.
Christopher T Ritchlin, Robert A Colbert, Dafna D Gladman. N Engl J Med 2017
603
37

Classification criteria for psoriatic arthritis: development of new criteria from a large international study.
William Taylor, Dafna Gladman, Philip Helliwell, Antonio Marchesoni, Philip Mease, Herman Mielants. Arthritis Rheum 2006
27

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
295
23

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Laura C Coates, Arthur Kavanaugh, Philip J Mease, Enrique R Soriano, Maria Laura Acosta-Felquer, April W Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli,[...]. Arthritis Rheumatol 2016
533
14

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Philip J Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang,[...]. Lancet 2020
106
12

Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
D D Gladman, C Antoni, P Mease, D O Clegg, P Nash. Ann Rheum Dis 2005
905
11

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Atul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, Alexa P Kollmeier, Elizabeth C Hsia, Ramanand A Subramanian, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou,[...]. Lancet 2020
108
10

The Epidemiology of Psoriatic Arthritis.
Alexis Ogdie, Pamela Weiss. Rheum Dis Clin North Am 2015
229
10

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
Philip Mease, Stephen Hall, Oliver FitzGerald, Désirée van der Heijde, Joseph F Merola, Francisco Avila-Zapata, Dorota Cieślak, Daniela Graham, Cunshan Wang, Sujatha Menon,[...]. N Engl J Med 2017
268
9

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
Iain B McInnes, Arthur Kavanaugh, Alice B Gottlieb, Lluís Puig, Proton Rahman, Christopher Ritchlin, Carrie Brodmerkel, Shu Li, Yuhua Wang, Alan M Mendelsohn,[...]. Lancet 2013
525
9

Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.
Jose U Scher, Alexis Ogdie, Joseph F Merola, Christopher Ritchlin. Nat Rev Rheumatol 2019
116
8

Comorbidities associated with psoriatic arthritis: Review and update.
Lourdes M Perez-Chada, Joseph F Merola. Clin Immunol 2020
48
16

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny,[...]. Arthritis Rheumatol 2019
185
8

Psoriasis.
Wolf-Henning Boehncke, Michael P Schön. Lancet 2015
8

Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.
Philip E Stuart, Rajan P Nair, Lam C Tsoi, Trilokraj Tejasvi, Sayantan Das, Hyun Min Kang, Eva Ellinghaus, Vinod Chandran, Kristina Callis-Duffin, Robert Ike,[...]. Am J Hum Genet 2015
184
8


Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors.
Dafna Gladman, William Rigby, Valderilio F Azevedo, Frank Behrens, Ricardo Blanco, Andrzej Kaszuba, Elizabeth Kudlacz, Cunshan Wang, Sujatha Menon, Thijs Hendrikx,[...]. N Engl J Med 2017
253
8

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.
Farzad Alinaghi, Monika Calov, Lars Erik Kristensen, Dafna D Gladman, Laura C Coates, Denis Jullien, Alice B Gottlieb, Paolo Gisondi, Jashin J Wu, Jacob P Thyssen,[...]. J Am Acad Dermatol 2019
201
8

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Philip J Mease, Désirée van der Heijde, Christopher T Ritchlin, Masato Okada, Raquel S Cuchacovich, Catherine L Shuler, Chen-Yen Lin, Daniel K Braun, Chin H Lee, Dafna D Gladman. Ann Rheum Dis 2017
313
8

Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis.
Kathryn J A Steel, Ushani Srenathan, Michael Ridley, Lucy E Durham, Shih-Ying Wu, Sarah E Ryan, Catherine D Hughes, Estee Chan, Bruce W Kirkham, Leonie S Taams. Arthritis Rheumatol 2020
47
17

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression.
Bina Menon, Nicola J Gullick, Gina J Walter, Megha Rajasekhar, Toby Garrood, Hayley G Evans, Leonie S Taams, Bruce W Kirkham. Arthritis Rheumatol 2014
174
8

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Iain B McInnes, Philip J Mease, Bruce Kirkham, Arthur Kavanaugh, Christopher T Ritchlin, Proton Rahman, Désirée van der Heijde, Robert Landewé, Philip G Conaghan, Alice B Gottlieb,[...]. Lancet 2015
530
8

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
Philip J Mease, Iain B McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, Robert Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan,[...]. N Engl J Med 2015
495
8


Comorbidities in Psoriatic Arthritis.
M Elaine Husni. Rheum Dis Clin North Am 2015
75
9

Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis.
Jennifer Belasco, James S Louie, Nicholas Gulati, Nathan Wei, Kristine Nograles, Judilyn Fuentes-Duculan, Hiroshi Mitsui, Mayte Suárez-Fariñas, James G Krueger. Arthritis Rheumatol 2015
76
9

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
Philip Mease, Laura C Coates, Philip S Helliwell, Mykola Stanislavchuk, Anna Rychlewska-Hanczewska, Anna Dudek, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Pille Harrison,[...]. Lancet 2018
102
7

Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.
Christopher T Ritchlin, Arthur Kavanaugh, Joseph F Merola, Georg Schett, Jose U Scher, Richard B Warren, Alice B Gottlieb, Deepak Assudani, Kathy Bedford-Rice, Jason Coarse,[...]. Lancet 2020
70
10

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.
Jonathan P Sherlock, Barbara Joyce-Shaikh, Scott P Turner, Cheng-Chi Chao, Manjiri Sathe, Jeff Grein, Daniel M Gorman, Edward P Bowman, Terrill K McClanahan, Jennifer H Yearley,[...]. Nat Med 2012
702
7

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd-Ruediger Burmester, David H Adams, Lisa Kerr, Chin Lee, Catherine L Shuler,[...]. Lancet 2017
224
7

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
Andrew Blauvelt, Andrea Chiricozzi. Clin Rev Allergy Immunol 2018
250
7

Clinical management of psoriatic arthritis.
Filip Van den Bosch, Laura Coates. Lancet 2018
52
13

Pathogenesis and clinical features of psoriasis.
Christopher Em Griffiths, Jonathan Nwn Barker. Lancet 2007
7

Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis.
Frank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, Nicole Yager, Lilian N Nwosu, Arthur G Pratt, Alicia Lledo Lara, Charlotte Guzzo, Ash Maroof, Lira Mamanova,[...]. Nat Commun 2020
51
13

Th17 and Th22 cells in psoriatic arthritis and psoriasis.
Helen Benham, Paul Norris, Jane Goodall, Mihir D Wechalekar, Oliver FitzGerald, Agnes Szentpetery, Malcolm Smith, Ranjeny Thomas, Hill Gaston. Arthritis Res Ther 2013
160
6

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.
John Bowes, Ashley Budu-Aggrey, Ulrike Huffmeier, Steffen Uebe, Kathryn Steel, Harry L Hebert, Chris Wallace, Jonathan Massey, Ian N Bruce, James Bluett,[...]. Nat Commun 2015
116
6

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison.
Joy Feld, Vinod Chandran, Nigil Haroon, Robert Inman, Dafna Gladman. Nat Rev Rheumatol 2018
89
6

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.
Monika M Schoels, Daniel Aletaha, Farideh Alasti, Josef S Smolen. Ann Rheum Dis 2016
210
6

Severe psoriasis--oral therapy with a new retinoid.
T Fredriksson, U Pettersson. Dermatologica 1978
6

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
M Rudwaleit, D van der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, J Braun, C T Chou, E Collantes-Estevez, M Dougados,[...]. Ann Rheum Dis 2009
6

Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions.
Lyn D Ferguson, Stefan Siebert, Iain B McInnes, Naveed Sattar. Nat Rev Rheumatol 2019
52
11

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.
Dennis G McGonagle, Iain B McInnes, Bruce W Kirkham, Jonathan Sherlock, Robert Moots. Ann Rheum Dis 2019
80
7

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Dominique Baeten, Joachim Sieper, Jürgen Braun, Xenofon Baraliakos, Maxime Dougados, Paul Emery, Atul Deodhar, Brian Porter, Ruvie Martin, Mats Andersson,[...]. N Engl J Med 2015
583
6


Secukinumab in plaque psoriasis--results of two phase 3 trials.
Richard G Langley, Boni E Elewski, Mark Lebwohl, Kristian Reich, Christopher E M Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson,[...]. N Engl J Med 2014
6

The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study.
Lihi Eder, Amir Haddad, Cheryl F Rosen, Ker-Ai Lee, Vinod Chandran, Richard Cook, Dafna D Gladman. Arthritis Rheumatol 2016
121
6

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
Iain B McInnes, Frank Behrens, Philip J Mease, Arthur Kavanaugh, Christopher Ritchlin, Peter Nash, Jordi Gratacós Masmitja, Philippe Goupille, Tatiana Korotaeva, Alice B Gottlieb,[...]. Lancet 2020
88
6


Comorbidities in psoriatic arthritis: a systematic review and meta-analysis.
Sonal Gupta, Zoe Syrimi, David M Hughes, Sizheng Steven Zhao. Rheumatol Int 2021
21
28

Obesity in early adulthood as a risk factor for psoriatic arthritis.
Razieh Soltani-Arabshahi, Bob Wong, Bing-Jian Feng, David E Goldgar, Kristina Callis Duffin, Gerald G Krueger. Arch Dermatol 2010
107
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.